BIANCHINI, GIAMPAOLO
BIANCHINI, GIAMPAOLO
Facoltà di Medicina e Chirurgia
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial
2025-01-01 Di Micco, R.; Botteri, E.; Canevari, C.; Gallivanone, F.; Antunovic, L.; Scifo, P.; Neri, I.; Gelardi, F.; Magnani, P.; Losio, C.; Venturini, E.; Della Vecchia, G.; Ferrarese, G.; Rotmensz, N.; Zuber, V.; Baleri, S.; Cisternino, G.; Calabretto, F.; Corona, S. P.; Rampa, M.; Pitoni, L.; Scaduto, V.; Morgante, M. M.; Critelli, A.; Sassi, I.; Bianchini, G.; Panizza, P.; Chiti, A.; Gentilini, O. D.
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
2012-01-01 Dutta, B; Pusztai, L; Qi, Y; André, F; Lazar, V; Bianchini, G; Ueno, N; Agarwal, R; Wang, B; Shiang, Cy; Hortobagyi, Gn; Mills, Gb; Symmans, Wf; Balázsi, G
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer after Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial
2025-01-01 Kalinsky, K.; Bianchini, G.; Hamilton, E.; Graff, S. L.; Park, K. H.; Jeselsohn, R.; Demirci, U.; Martin, M.; Layman, R. M.; Hurvitz, S. A.; Sammons, S.; Kaufman, P. A.; Munoz, M.; Lai, J. -I.; Knoderer, H.; Sandoval, C.; Chawla, A. R.; Nguyen, B.; Zhou, Y.; Ravenberg, E.; Litchfield, L. M.; Smyth, L.; Wander, S. A.
Accurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samples.
2014-01-01 Callari, M; Lembo, A; Bianchini, G; Musella, V; Cappelletti, V; Gianni, L; Daidone, Mg; Provero, P.
An unmet need: tailoring extended adjuvant endocrine therapy.
2013-01-01 Bianchini, G; Gianni, L
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach.
2016-01-01 Safonov, A; Wang, S; Gross, Cp; Agarwal, D; Bianchini, G; Pusztai, L; Hatzis, C.
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer
2017-01-01 Karn, T; Jiang, T; Hatzis, C; Sänger, N; El-Balat, A; Rody, A; Holtrich, U; Becker, S; Bianchini, G; Pusztai, L.
Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies
2025-01-01 Ungvari, Z.; Fekete, M.; Varga, P.; Lehoczki, A.; Munkacsy, G.; Fekete, J. T.; Bianchini, G.; Ocana, A.; Buda, A.; Ungvari, A.; Gyorffy, B.
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer
2022-01-01 Hurvitz, S. A.; Bachelot, T.; Bianchini, G.; Harbeck, N.; Loi, S.; Park, Y. H.; Prat, A.; Gilham, L.; Boulet, T.; Monturus, N. G. E.; Lambertini, C.; Nyawira, B.; Knott, A.; Restuccia, E.; Schmid, P.
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen
2012-01-01 Pietrantonio, Filippo; Biondani, Pamela; de Braud, Filippo; Pellegrinelli, Alessandro; Bianchini, Gianpaolo; Perrone, Federica; Formisano, Barbara; Di Bartolomeo, Maria
Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy
2026-01-01 Notini, G.; Bianchini, G.; Pérez-García, J. M.; Cortés, J.
BIOLOGICAL PROCESSES ASSOCIATED WITH PROGNOSIS AND CHEMOTHERAPY SENSITIVITY IN MOLECULAR SUBTYPES OF BREAST CANCER
2011-01-01 Iwamoto, T; Bianchini, G; Booser, D; Qi, Y; Coutant, C; Shiang, C; Santarpia, L; Matsuoka, J; Hortobagyi, Gn; Symmans, Wf; Holmes, F; O'Shaughnessy, J; Hellerstedt, B; Pippen, J; Andre, F; Simon, R; Pusztai, L
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
2017-01-01 Bianchini, G; Kiermaier, A; Bianchi, Gv; Im, Yh; Pienkowski, T; Liu, Mc; Tseng, Lm; Dowsett, M; Zabaglo, L; Kirk, S; Szado, T; Eng-Wong, J; Amler, Lc; Valagussa, P; Gianni, L.
Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)
2024-01-01 Dri, A.; Arpino, G.; Bianchini, G.; Curigliano, G.; Danesi, R.; De Laurentiis, M.; Del Mastro, L.; Fabi, A.; Generali, D.; Gennari, A.; Guarneri, V.; Santini, D.; Simoncini, E.; Zamagni, C.; Puglisi, F.
BREAST CANCER GENOMICS: CHALLENGES IN INTERPRETATION AND APPLICATION
2013-01-01 Kelly, Cm; Symmans, Wf; Andreopoulou, E; Bianchini, G
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy
2023-01-01 Licata, L.; Barreca, M.; Galbardi, B.; Dugo, M.; Viale, G.; Gyorffy, B.; Karn, T.; Pusztai, L.; Gianni, L.; Callari, M.; Bianchini, G.
Breastfeeding after breast cancer in young BRCA carriers
2025-01-01 Blondeaux, E.; Delucchi, V.; Mariamidze, E.; Bernstein-Molho, R.; Frank, S.; Ferrari, A.; Linn, S.; Kim, H. J.; Agostinetto, E.; Paluch-Shimon, S.; Cortesi, L.; Di Meglio, A.; Balmana, J.; Yerushalmi, R.; Rodriguez-Wallberg, K. A.; Renaud, T.; Cui, W.; Moore, H. C. F.; Wong, S. M.; Pogoda, K.; Lustberg, M.; Phillips, K. A.; Han, S.; Puglisi, F.; Vernieri, C.; Bajpai, J.; Sonnenblick, A.; Rousset-Jablonski, C.; De Marchis, L.; De Giorgi, U.; Bianchini, G.; Texeira, L.; Duhoux, F. P.; Villarreal-Garza, C.; Sini, V.; Fruscio, R.; Del Mastro, L.; Demeestere, I.; Azim, H. A.; Peccatori, F. A.; Partridge, A. H.; Lambertini, M.
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
2026-01-01 Park, Y. H.; Cortes, J.; Modi, S.; Hurvitz, S. A.; Bianchini, G.; Iwata, H.; Shitara, K.; Siena, S.; Goto, Y.; Ku, G. Y.; Powell, C. A.; Swain, S. M.; Arunachalam, M.; Janek, M.; Cheng, Y.; Chu, C.; Verma, P.; Kuptsova-Clarkson, N.; Mathias, E.; Goodman, E.; Rugo, H. S.
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
2021-01-01 Gelmon, K. A.; Fasching, P. A.; Couch, F. J.; Balmana, J.; Delaloge, S.; Labidi-Galy, I.; Bennett, J.; Mccutcheon, S.; Walker, G.; O'Shaughnessy, J.; Collaborating, Investigators; Bianchini, G; Santoro, A
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
2025-01-01 Scafetta, R.; Donato, M.; Gullotta, C.; Guarino, A.; Fiore, C.; Sisca, L.; Speziale, E.; Troiano, R.; Foderaro, S.; Ricozzi, V.; Iuliani, M.; Simonetti, S.; Cavaliere, S.; Cortellini, A.; Botticelli, A.; Scagnoli, S.; Pisegna, S.; Criscitiello, C.; Pedersini, R.; Sposetti, C.; Tiberi, E.; D'Auria, G.; Vergati, M.; Mazzotta, M.; Caputo, R.; Verrazzo, A.; Rossino, M. G.; Domati, F.; Piombino, C.; Di Lisa, F. S.; Filomeno, L.; Arcuri, T.; Puce, F.; Riva, F.; Palleschi, M.; Sirico, M.; Piras, M.; Stucci, L. S.; De Lisi, D.; Orsaria, P.; Ippolito, E.; Ramella, S.; Visani, L.; Bertini, N.; Bonaparte, I.; Gori, S.; Rossi, L.; Meattini, I.; Tagliaferri, B.; Caffo, O.; Portarena, I.; Irelli, A.; Cretella, E.; Porta, C.; Bianchini, G.; Fabbri, A.; De Giorgi, U.; Vici, P.; Toss, A.; Garrone, O.; De Laurentiis, M.; Villa, F.; Berardi, R.; Minelli, M.; Vernieri, C.; Curigliano, G.; Vincenzi, B.; Tonini, G.; Santini, D.; Pantano, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial | 1-gen-2025 | Di Micco, R.; Botteri, E.; Canevari, C.; Gallivanone, F.; Antunovic, L.; Scifo, P.; Neri, I.; Gelardi, F.; Magnani, P.; Losio, C.; Venturini, E.; Della Vecchia, G.; Ferrarese, G.; Rotmensz, N.; Zuber, V.; Baleri, S.; Cisternino, G.; Calabretto, F.; Corona, S. P.; Rampa, M.; Pitoni, L.; Scaduto, V.; Morgante, M. M.; Critelli, A.; Sassi, I.; Bianchini, G.; Panizza, P.; Chiti, A.; Gentilini, O. D. | |
| A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. | 1-gen-2012 | Dutta, B; Pusztai, L; Qi, Y; André, F; Lazar, V; Bianchini, G; Ueno, N; Agarwal, R; Wang, B; Shiang, Cy; Hortobagyi, Gn; Mills, Gb; Symmans, Wf; Balázsi, G | |
| Abemaciclib Plus Fulvestrant in Advanced Breast Cancer after Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial | 1-gen-2025 | Kalinsky, K.; Bianchini, G.; Hamilton, E.; Graff, S. L.; Park, K. H.; Jeselsohn, R.; Demirci, U.; Martin, M.; Layman, R. M.; Hurvitz, S. A.; Sammons, S.; Kaufman, P. A.; Munoz, M.; Lai, J. -I.; Knoderer, H.; Sandoval, C.; Chawla, A. R.; Nguyen, B.; Zhou, Y.; Ravenberg, E.; Litchfield, L. M.; Smyth, L.; Wander, S. A. | |
| Accurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samples. | 1-gen-2014 | Callari, M; Lembo, A; Bianchini, G; Musella, V; Cappelletti, V; Gianni, L; Daidone, Mg; Provero, P. | |
| An unmet need: tailoring extended adjuvant endocrine therapy. | 1-gen-2013 | Bianchini, G; Gianni, L | |
| Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach. | 1-gen-2016 | Safonov, A; Wang, S; Gross, Cp; Agarwal, D; Bianchini, G; Pusztai, L; Hatzis, C. | |
| Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer | 1-gen-2017 | Karn, T; Jiang, T; Hatzis, C; Sänger, N; El-Balat, A; Rody, A; Holtrich, U; Becker, S; Bianchini, G; Pusztai, L. | |
| Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies | 1-gen-2025 | Ungvari, Z.; Fekete, M.; Varga, P.; Lehoczki, A.; Munkacsy, G.; Fekete, J. T.; Bianchini, G.; Ocana, A.; Buda, A.; Ungvari, A.; Gyorffy, B. | |
| ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer | 1-gen-2022 | Hurvitz, S. A.; Bachelot, T.; Bianchini, G.; Harbeck, N.; Loi, S.; Park, Y. H.; Prat, A.; Gilham, L.; Boulet, T.; Monturus, N. G. E.; Lambertini, C.; Nyawira, B.; Knott, A.; Restuccia, E.; Schmid, P. | |
| Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen | 1-gen-2012 | Pietrantonio, Filippo; Biondani, Pamela; de Braud, Filippo; Pellegrinelli, Alessandro; Bianchini, Gianpaolo; Perrone, Federica; Formisano, Barbara; Di Bartolomeo, Maria | |
| Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy | 1-gen-2026 | Notini, G.; Bianchini, G.; Pérez-García, J. M.; Cortés, J. | |
| BIOLOGICAL PROCESSES ASSOCIATED WITH PROGNOSIS AND CHEMOTHERAPY SENSITIVITY IN MOLECULAR SUBTYPES OF BREAST CANCER | 1-gen-2011 | Iwamoto, T; Bianchini, G; Booser, D; Qi, Y; Coutant, C; Shiang, C; Santarpia, L; Matsuoka, J; Hortobagyi, Gn; Symmans, Wf; Holmes, F; O'Shaughnessy, J; Hellerstedt, B; Pippen, J; Andre, F; Simon, R; Pusztai, L | |
| Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer | 1-gen-2017 | Bianchini, G; Kiermaier, A; Bianchi, Gv; Im, Yh; Pienkowski, T; Liu, Mc; Tseng, Lm; Dowsett, M; Zabaglo, L; Kirk, S; Szado, T; Eng-Wong, J; Amler, Lc; Valagussa, P; Gianni, L. | |
| Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs) | 1-gen-2024 | Dri, A.; Arpino, G.; Bianchini, G.; Curigliano, G.; Danesi, R.; De Laurentiis, M.; Del Mastro, L.; Fabi, A.; Generali, D.; Gennari, A.; Guarneri, V.; Santini, D.; Simoncini, E.; Zamagni, C.; Puglisi, F. | |
| BREAST CANCER GENOMICS: CHALLENGES IN INTERPRETATION AND APPLICATION | 1-gen-2013 | Kelly, Cm; Symmans, Wf; Andreopoulou, E; Bianchini, G | |
| Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy | 1-gen-2023 | Licata, L.; Barreca, M.; Galbardi, B.; Dugo, M.; Viale, G.; Gyorffy, B.; Karn, T.; Pusztai, L.; Gianni, L.; Callari, M.; Bianchini, G. | |
| Breastfeeding after breast cancer in young BRCA carriers | 1-gen-2025 | Blondeaux, E.; Delucchi, V.; Mariamidze, E.; Bernstein-Molho, R.; Frank, S.; Ferrari, A.; Linn, S.; Kim, H. J.; Agostinetto, E.; Paluch-Shimon, S.; Cortesi, L.; Di Meglio, A.; Balmana, J.; Yerushalmi, R.; Rodriguez-Wallberg, K. A.; Renaud, T.; Cui, W.; Moore, H. C. F.; Wong, S. M.; Pogoda, K.; Lustberg, M.; Phillips, K. A.; Han, S.; Puglisi, F.; Vernieri, C.; Bajpai, J.; Sonnenblick, A.; Rousset-Jablonski, C.; De Marchis, L.; De Giorgi, U.; Bianchini, G.; Texeira, L.; Duhoux, F. P.; Villarreal-Garza, C.; Sini, V.; Fruscio, R.; Del Mastro, L.; Demeestere, I.; Azim, H. A.; Peccatori, F. A.; Partridge, A. H.; Lambertini, M. | |
| Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies | 1-gen-2026 | Park, Y. H.; Cortes, J.; Modi, S.; Hurvitz, S. A.; Bianchini, G.; Iwata, H.; Shitara, K.; Siena, S.; Goto, Y.; Ku, G. Y.; Powell, C. A.; Swain, S. M.; Arunachalam, M.; Janek, M.; Cheng, Y.; Chu, C.; Verma, P.; Kuptsova-Clarkson, N.; Mathias, E.; Goodman, E.; Rugo, H. S. | |
| Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis | 1-gen-2021 | Gelmon, K. A.; Fasching, P. A.; Couch, F. J.; Balmana, J.; Delaloge, S.; Labidi-Galy, I.; Bennett, J.; Mccutcheon, S.; Walker, G.; O'Shaughnessy, J.; Collaborating, Investigators; Bianchini, G; Santoro, A | |
| Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors | 1-gen-2025 | Scafetta, R.; Donato, M.; Gullotta, C.; Guarino, A.; Fiore, C.; Sisca, L.; Speziale, E.; Troiano, R.; Foderaro, S.; Ricozzi, V.; Iuliani, M.; Simonetti, S.; Cavaliere, S.; Cortellini, A.; Botticelli, A.; Scagnoli, S.; Pisegna, S.; Criscitiello, C.; Pedersini, R.; Sposetti, C.; Tiberi, E.; D'Auria, G.; Vergati, M.; Mazzotta, M.; Caputo, R.; Verrazzo, A.; Rossino, M. G.; Domati, F.; Piombino, C.; Di Lisa, F. S.; Filomeno, L.; Arcuri, T.; Puce, F.; Riva, F.; Palleschi, M.; Sirico, M.; Piras, M.; Stucci, L. S.; De Lisi, D.; Orsaria, P.; Ippolito, E.; Ramella, S.; Visani, L.; Bertini, N.; Bonaparte, I.; Gori, S.; Rossi, L.; Meattini, I.; Tagliaferri, B.; Caffo, O.; Portarena, I.; Irelli, A.; Cretella, E.; Porta, C.; Bianchini, G.; Fabbri, A.; De Giorgi, U.; Vici, P.; Toss, A.; Garrone, O.; De Laurentiis, M.; Villa, F.; Berardi, R.; Minelli, M.; Vernieri, C.; Curigliano, G.; Vincenzi, B.; Tonini, G.; Santini, D.; Pantano, F. |